Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents $ 1,675,673 $ 4,220,225
Restricted cash 325,670 325,181
Accounts receivable - project revenue and reimbursable project costs 255,035 469,086
Prepaid expenses and other current assets 112,569 205,185
Total Current Assets 2,368,947 5,219,677
Other Assets    
Patent costs 893,187 833,560
Total Assets 3,262,134 6,053,237
Current Liabilities    
Accounts payable and accrued liabilities 608,346 653,669
Total Current Liabilities 608,346 653,669
Warrant liability 1,891,566 4,633,312
Total Liabilities $ 2,499,912 $ 5,286,981
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding $ 0 $ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,523,453 shares outstanding at September 30, 2015 and 18,082,874 at December 31, 2014 18,523 18,083
Additional paid-in capital 71,873,603 70,801,464
Accumulated Deficit (71,129,904) (70,053,291)
Total Stockholders' Equity 762,222 766,256
Total Liabilities and Stockholders' Equity $ 3,262,134 $ 6,053,237